Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,009 | 3,056 | 2,754 | 16,361 | 12,598 |
| Gross Profit | 11,009 | 3,056 | 2,754 | 16,361 | 12,598 |
| Operating Expenses | 18,676 | 27,573 | 27,266 | 31,172 | 24,667 |
| Operating Income | -7,667 | -24,517 | -24,512 | -14,811 | -12,069 |
| Interest Expense | 394 | 674 | 775 | 903 | 986 |
| Other Income | 516 | 895 | 1,164 | 1,597 | 1,972 |
| Pre-tax Income | -7,545 | -24,296 | -24,123 | -14,117 | -11,083 |
| Income Tax | N/A | N/A | N/A | N/A | 418 |
| Net Income Continuous | -7,545 | -24,296 | -24,123 | -14,117 | -11,501 |
| Net Income | $-7,545 | $-24,296 | $-24,123 | $-14,117 | $-11,501 |
| EPS Basic Total Ops | -1.51 | -4.87 | -4.75 | -2.70 | -2.34 |
| EPS Basic Continuous Ops | -1.51 | -4.87 | -4.85 | -2.84 | -2.34 |
| EPS Diluted Total Ops | -1.51 | -4.87 | -4.75 | -2.70 | -2.34 |
| EPS Diluted Continuous Ops | -1.51 | -4.87 | -4.85 | -2.84 | -2.34 |
| EPS Diluted Before Non-Recurring Items | -1.51 | -4.08 | -4.75 | -2.75 | -2.25 |
| EBITDA(a) | $-7,584 | $-24,230 | $-24,336 | $-14,993 | $-12,600 |